Stock 1C0S CELYAD ONCOLOGY SA
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Celyad Oncology SA BOERSE MUENCHEN

Equities

1C0S

US1512052002

Real-time BOERSE MUENCHEN
Other stock markets
 		5-day change 1st Jan Change
- EUR -.--% Intraday chart for Celyad Oncology SA +10.27% -.--%
04-04 Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI
02-09 Celyad Oncology Seeks Termination of Reporting Obligations to US SEC MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
MODERNA, INC. Stock Moderna, Inc.
 45.34B -
LONZA GROUP AG Stock Lonza Group AG
 40.42B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 37.92B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 31.75B -
CELLTRION, INC. Stock Celltrion, Inc.
 27.71B
  1. Stock Market
  2. Equities
  3. CYAD Stock
  4. 1C0S Stock
  5. Charts Celyad Oncology SA
  6. Sector Chart